20002019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicola Colombo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., 2019, In : Annals of Oncology. 30, 7, p. 1080-1087 8 p.

Research output: Contribution to journalArticle

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study: Annals of Oncology

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., 2019, In : Ann. Oncol.. 30, 7, p. 1080-1087 8 p.

Research output: Contribution to journalArticle

  • BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories

    Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., Dec 1 2019, In : Diagnostics. 9, 4, p. 1-10 10 p., 46.

    Research output: Contribution to journalArticle

  • BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories

    Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., 2019, In : Diagnostics. 9, 4

    Research output: Contribution to journalArticle

    Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

    Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

    Research output: Contribution to journalArticle